U.S. flag

An official website of the United States government

FL-21-0011

CMS is approving this time-limited state plan amendment to respond to the COVID-19 national emergency.  The purpose of this amendment is to add an end date to previously approved emergency provisions due to the COVID-19 Public Health Emergency.

UT-22-0002

The SPA provides assurances that the State complies with federal requirements regarding coverage of routine patient care associated with participation in clinical trials as required by the Consolidated Appropriations Act, 2021.

DC-21-0010

To allow the District to transition its Section 1115 Behavioral Health Transformation Demonstration Program services to permanent State Plan authority in order to retain authority to provide Medicaid reimbursement.

NJ-22-0010

The state proposes to include assurances that the state complies with Third Party Liability rules as authorized under both the Bipartisan Budget Act of 2018 and the Medicaid Services Investment and Accountability Act of 2019. The state has submitted this SPA per the guidance issued in August 2021. CMS supports this change.

NV-22-0006

This SPA amends to bring Nevada's state plan into compliance with specific third-party liability requirements outlined in the Bipartisan Budget Act of 2018 and the Medicaid Services Investment and Accountability Act of 2019.

WI-22-0007

This amendment provides attestation to coverage of usual and customary care for Wisconsin Medicaid beneficiaries participating in clinical trials as required by the Consolidated Appropriations Act of 2021 Effective January 1, 2022.

WA-22-1000

This SPA demonstrates compliance with requirements in the American Rescue Plan Act of 2021 (ARP) that 1) mandate coverage of COVID-19 testing, treatment, and vaccines and their administration without cost-sharing or amount, duration, or scope limitations; and 2) require states to cover, without cost sharing, the treatment of conditions that may seriously complicate COVID- 19 treatment, during the period when a beneficiary is diagnosed with or is presumed to have COVID-19.

LA-22-0004

CMS is approving this time-limited state plan amendment to respond to the COVID-19 national emergency. The purpose of this amendment is to cover the new optional group for COVID testing, suspend all cost sharing, extend all prior authorization by automatic renewal without clinical review or time/quantity extensions, expand telehealth, adjust prior authorizations for medications, and increase certain payment rates.
Subscribe to